This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Jan 22;321(3):316.

doi: 10.1001/jama.2018.20751.

Breast Cancer Treatment

Adrienne G Waks¹, Eric P Winer¹

Affiliations

PMID: 30667503
DOI: 10.1001/jama.2018.20751

Breast Cancer Treatment

Adrienne G Waks et al. JAMA. 2019.

. 2019 Jan 22;321(3):316.

doi: 10.1001/jama.2018.20751.

Authors

Adrienne G Waks¹, Eric P Winer¹

Affiliation

¹ Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 30667503
DOI: 10.1001/jama.2018.20751

No abstract available

PubMed Disclaimer

Original report in

Breast Cancer Treatment: A Review.
Waks AG, Winer EP. Waks AG, et al. JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323. JAMA. 2019. PMID: 30667505 Review.

Similar articles

Estrogen and progesterone receptors as prognostic factors in early breast cancer.
Saez S, Cheix F, Mayer M. Saez S, et al. Recent Results Cancer Res. 1984;91:192-8. doi: 10.1007/978-3-642-82188-2_27. Recent Results Cancer Res. 1984. PMID: 6729216 No abstract available.
[Molecular subtypes and individualized treatment of breast cancer].
Xu BH, Zhang P. Xu BH, et al. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):641-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122374 Review. Chinese. No abstract available.
Medical treatment for advanced breast cancer.
Carbone PP, Davis TE. Carbone PP, et al. Semin Oncol. 1978 Dec;5(4):417-27. Semin Oncol. 1978. PMID: 366755 Review. No abstract available.
Progesterone receptor testing: not the right time to be buried.
Colozza M, Larsimont D, Piccart MJ. Colozza M, et al. J Clin Oncol. 2005 Jun 1;23(16):3867-8; author reply 3869-70. doi: 10.1200/JCO.2005.05.167. J Clin Oncol. 2005. PMID: 15923594 No abstract available.
Current concepts in cancer. Receptors in breast cancer.
Lippman ME, Allegra JC. Lippman ME, et al. N Engl J Med. 1978 Oct 26;299(17):930-3. doi: 10.1056/NEJM197810262991706. N Engl J Med. 1978. PMID: 692599 No abstract available.

See all similar articles

Cited by

CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer.
Han XL, Du J, Zheng YD, Dai JJ, Lin SW, Zhang BY, Zhong FB, Lin ZG, Jiang SQ, Wei W, Fang ZY. Han XL, et al. Biomed Res Int. 2021 Apr 17;2021:5089371. doi: 10.1155/2021/5089371. eCollection 2021. Biomed Res Int. 2021. PMID: 33959656 Free PMC article.
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
Cai M, Li H, Chen R, Zhou X. Cai M, et al. Cancer Manag Res. 2021 Feb 25;13:2009-2024. doi: 10.2147/CMAR.S296038. eCollection 2021. Cancer Manag Res. 2021. PMID: 33658859 Free PMC article.
Extrachromosomal circular DNA: biogenesis, structure, functions and diseases.
Yang L, Jia R, Ge T, Ge S, Zhuang A, Chai P, Fan X. Yang L, et al. Signal Transduct Target Ther. 2022 Oct 2;7(1):342. doi: 10.1038/s41392-022-01176-8. Signal Transduct Target Ther. 2022. PMID: 36184613 Free PMC article. Review.
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype.
Asemota S, Effah W, Young KL, Holt J, Cripe L, Ponnusamy S, Thiyagarajan T, Hwang DJ, He Y, Mcnamara K, Johnson D, Wang Y, Grimes B, Khosrosereshki Y, Hollingsworth TJ, Fleming MD, Pritchard FE, Hendrix A, Khan F, Fan M, Makowski L, Yin Z, Sasano H, Hayes DN, Pfeffer LM, Miller DD, Narayanan R. Asemota S, et al. Cell Rep. 2023 Dec 26;42(12):113461. doi: 10.1016/j.celrep.2023.113461. Epub 2023 Nov 17. Cell Rep. 2023. PMID: 37979170 Free PMC article.
The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer.
Zhao R, Wang W, Pan L, Lv X, He Y, Lian W, Ma Y, Zhang X, Yu R, Zhao S, Guo X, Huang T, Peng M. Zhao R, et al. Front Oncol. 2023 Feb 9;13:1047973. doi: 10.3389/fonc.2023.1047973. eCollection 2023. Front Oncol. 2023. PMID: 36845750 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information